| Dr Jose E Catibog, MD | |
|
1061 Harmon Ave, Fort Stewart, GA 31314-5641 | |
| (912) 435-5555 | |
| Not Available |
| Full Name | Dr Jose E Catibog |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 1061 Harmon Ave, Fort Stewart, Georgia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922109115 | NPI | - | NPPES |
| 1991741 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 10486R (Louisiana) | Secondary |
| 208000000X | Pediatrics | LA10486R (Louisiana) | Primary |
| Entity Name | C & M Medical Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710903059 PECOS PAC ID: 9436061553 Enrollment ID: O20050121000093 |
News Archive
Nile Therapeutics, Inc., a biopharmaceutical company focused on the development of novel therapeutics for cardiovascular disease, today announced that it has completed the dosing of the last patient in NIL-CDNP-CT005, an open-label, single-blind, placebo-controlled Phase II study of CD-NP in patients with acute decompensated heart failure, or ADHF. The study was designed to provide additional information on the safety and tolerability of CD-NP when infused for up to 72 hours in patients with ADHF and mild to moderate renal insufficiency.
The Annual Report to the Nation on the Status of Cancer, covering the period 1975, showed death rates for lung cancer, which accounts for more than one in four cancer deaths, dropping at a faster pace than in previous years. The recent larger drop in lung cancer deaths is likely the result of decreased cigarette smoking prevalence over many years, and is now being reflected in mortality trends. The lung cancer death rate decline, as well as declines in colorectal, breast, and prostate cancer death rates, has also helped drive decreases in death rates for all cancers types combined, a trend that began about 20 years ago.
Aeterna Zentaris Inc. today announced that a poster on its highly selective Erk 1/2 inhibitor anticancer compound, AEZS-131, was presented at the 102nd annual meeting of the American Association for Cancer Research currently held at the Orange County Convention Center in Orlando, Florida.
LifeWatch AG, a leading developer and provider of medical solutions and remote diagnostic monitoring services in the digital health market, is pleased to announce that it has received FDA clearance for its continuous Vital Signs Monitoring Service.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jose E Catibog, MD 1061 Harmon Avenue, Ft Stewart, GA 31314 Ph: (912) 435-5555 | Dr Jose E Catibog, MD 1061 Harmon Ave, Fort Stewart, GA 31314-5641 Ph: (912) 435-5555 |
News Archive
Nile Therapeutics, Inc., a biopharmaceutical company focused on the development of novel therapeutics for cardiovascular disease, today announced that it has completed the dosing of the last patient in NIL-CDNP-CT005, an open-label, single-blind, placebo-controlled Phase II study of CD-NP in patients with acute decompensated heart failure, or ADHF. The study was designed to provide additional information on the safety and tolerability of CD-NP when infused for up to 72 hours in patients with ADHF and mild to moderate renal insufficiency.
The Annual Report to the Nation on the Status of Cancer, covering the period 1975, showed death rates for lung cancer, which accounts for more than one in four cancer deaths, dropping at a faster pace than in previous years. The recent larger drop in lung cancer deaths is likely the result of decreased cigarette smoking prevalence over many years, and is now being reflected in mortality trends. The lung cancer death rate decline, as well as declines in colorectal, breast, and prostate cancer death rates, has also helped drive decreases in death rates for all cancers types combined, a trend that began about 20 years ago.
Aeterna Zentaris Inc. today announced that a poster on its highly selective Erk 1/2 inhibitor anticancer compound, AEZS-131, was presented at the 102nd annual meeting of the American Association for Cancer Research currently held at the Orange County Convention Center in Orlando, Florida.
LifeWatch AG, a leading developer and provider of medical solutions and remote diagnostic monitoring services in the digital health market, is pleased to announce that it has received FDA clearance for its continuous Vital Signs Monitoring Service.
› Verified 5 days ago
Dr. Richard Eden Kauff, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1061 Harmon Ave, Suite 1d03, Fort Stewart, GA 31314 Phone: 912-435-5555 | |
Dr. Matthew James Fults, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 1061 Harmon Ave, Fort Stewart, GA 31314 Phone: 912-435-5687 | |
Jose A Hernandez, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1061 Harmon Ave, Ste 1d03, Fort Stewart, GA 31314 Phone: 912-435-6819 | |
Dr. Tometricia Brown, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1061 Harmon Ave, Fort Stewart, GA 31314 Phone: 912-435-6965 | |
Benjamin Jack, DO Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1061 Harmon Ave, Fort Stewart, GA 31314 Phone: 912-435-6965 | |
Dr. Charity Omejiyovbi Akpolo, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1061 Harmon Ave, Fort Stewart, GA 31314 Phone: 912-435-5555 Fax: 912-435-5954 | |
German Rene Gonzalez Ramos, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1061 Harmon Avenue, Fort Stewart, GA 31314 Phone: 912-435-5555 |